Asha S. Collins's most recent trade in Idexx Laboratories, Inc. was a trade of 609 Non-Qualified Stock Option (right-to-buy) done . Disclosure was reported to the exchange on May 6, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
IDEXX Laboratories | Asha S. Collins | Director | 06 May 2024 | 609 | 609 | - | - | Non-Qualified Stock Option (right-to-buy) | ||
IDEXX Laboratories | Asha S. Collins | Director | 06 May 2024 | 262 | 262 | - | - | Restricted Stock Unit | ||
IDEXX Laboratories | Asha S. Collins | Director | 06 May 2024 | 257 | 779 (0%) | 0% | 0 | Common Stock | ||
IDEXX Laboratories | Asha S. Collins | Director | 06 May 2024 | 257 | 0 | - | - | Restricted Stock Unit | ||
IDEXX Laboratories | Asha S. Collins | Director | 17 May 2023 | 645 | 645 | - | - | Non-Qualified Stock Option (right-to-buy) | ||
IDEXX Laboratories | Asha S. Collins | Director | 17 May 2023 | 257 | 257 | - | - | Restricted Stock Unit | ||
IDEXX Laboratories | Asha S. Collins | Director | 11 May 2023 | 344 | 0 | - | - | Restricted Stock Unit | ||
IDEXX Laboratories | Asha S. Collins | Director | 11 May 2023 | 344 | 522 (0%) | 0% | 0 | Common Stock | ||
IDEXX Laboratories | Asha S. Collins | Director | 11 May 2022 | 945 | 945 | - | - | Non-Qualified Stock Option (right-to-buy) | ||
IDEXX Laboratories | Asha S. Collins | Director | 11 May 2022 | 344 | 344 | - | - | Restricted Stock Unit | ||
IDEXX Laboratories | Asha S. Collins | Director | 28 Jan 2022 | 41 | 178 (0%) | 0% | 489.0 | 20,051 | Common Stock | |
IDEXX Laboratories | Asha S. Collins | Director | 29 Oct 2021 | 30 | 137 (0%) | 0% | 666.1 | 19,984 | Common Stock | |
IDEXX Laboratories | Asha S. Collins | Director | 30 Jul 2021 | 29 | 107 (0%) | 0% | 678.5 | 19,677 | Common Stock | |
IDEXX Laboratories | Asha S. Collins | Director | 12 May 2021 | 723 | 723 | - | - | Non-Qualified Stock Option (right-to-buy) | ||
IDEXX Laboratories | Asha S. Collins | Director | 12 May 2021 | 224 | 333 | - | - | Deferred Stock Unit | ||
IDEXX Laboratories | Asha S. Collins | Director | 30 Apr 2021 | 36 | 78 (0%) | 0% | 549 | 19,764 | Common Stock | |
IDEXX Laboratories | Asha S. Collins | Director | 29 Jan 2021 | 42 | 42 (0%) | 0% | 478.7 | 20,105 | Common Stock | |
IDEXX Laboratories | Asha S. Collins | Director | 01 Dec 2020 | 358 | 358 | - | - | Non-Qualified Stock Option (right-to-buy) | ||
IDEXX Laboratories | Asha S. Collins | Director | 01 Dec 2020 | 109 | 109 | - | - | Deferred Stock Unit |